Characterization of human carbonic anhydrase XII stability and inhibitor binding

Vaida Jogaitė1, Asta Zubrienė, Vilma Michailovienė

  • 1Department of Biothermodynamics and Drug Design, Vilnius University Institute of Biotechnology, Graičiūno 8, Vilnius LT-02241, Lithuania.

Insights

Human carbonic anhydrase XII (CA XII) is an anticancer target. We characterized sulfonamide inhibitor binding thermodynamics, revealing pH and buffer-dependent interactions crucial for designing specific CA XII anticancer drugs.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Pharmacology

Background:

  • Human carbonic anhydrase isozyme XII (CA XII) is a transmembrane protein.
  • CA XII is overexpressed in various human cancers, making it a significant anticancer drug target.
  • Currently, limited compounds specifically target CA XII, necessitating further research into inhibitor design.

Purpose of the Study:

  • To characterize the thermodynamic parameters of sulfonamide inhibitor binding to CA XII.
  • To understand the influence of buffer and pH on inhibitor binding.
  • To provide insights into the structural features and binding mechanisms for developing specific CA XII inhibitors.

Main Methods:

  • Isothermal titration calorimetry (ITC) was employed to measure binding thermodynamics.
  • Fluorescent thermal shift assay (FTSA) was used to assess protein stability and binding.
  • Protonation-deprotonation reactions of active site water and inhibitor groups were analyzed.

Main Results:

  • Sulfonamide binding to CA XII demonstrated significant dependence on buffer composition and pH.
  • Intrinsic thermodynamic parameters (enthalpy, entropy, Gibbs free energy) of binding were determined.
  • CA XII stability was evaluated across different pH conditions and in the presence of various buffers and salts.

Conclusions:

  • The study elucidates the thermodynamic basis of sulfonamide binding to CA XII.
  • Understanding these binding characteristics is essential for the rational design of novel CA XII-specific anticancer agents.
  • The findings highlight the importance of considering solution conditions in drug design targeting CA XII.

Related Concept Videos

Enzyme Inhibition01:30

Enzyme Inhibition

Inhibitors are molecules that reduce enzyme activity by binding to the enzyme. In a normally functioning cell, enzymes are regulated by a variety of inhibitors. Drugs and other toxins can also inhibit enzymes. Some inhibitors bind to the enzyme’s active site, while others inhibit enzymatic activity by binding to other sites on the protein structure.
Allosteric Proteins-ATCase01:19

Allosteric Proteins-ATCase

Binding sites linkages can regulate a protein's function.  For example, enzyme activity is often regulated through a feedback mechanism where the end product of the biochemical process serves as an inhibitor.
Aspartate transcarbamoylase (ATCase) is a cytosolic enzyme that catalyzes the condensation of L-aspartate and carbamoyl phosphate to  N-carbamoyl-L-aspartate. This reaction is the first step in pyrimidine biosynthesis. UTP and CTP, the end products of the pyrimidine synthesis pathway,...
The Equilibrium Binding Constant and Binding Strength02:18

The Equilibrium Binding Constant and Binding Strength

The equilibrium binding constant (Kb) quantifies the strength of a protein-ligand interaction. Kb can be calculated as follows when the reaction is at equilibrium:
Introduction to Mechanisms of Enzyme Catalysis01:13

Introduction to Mechanisms of Enzyme Catalysis

For many years, scientists thought that enzyme-substrate binding took place in a simple "lock-and-key" fashion. This model stated that the enzyme and substrate fit together perfectly in one instantaneous step. However, current research supports a more refined view scientists call induced fit. The induced-fit model expands upon the lock-and-key model by describing a more dynamic interaction between enzyme and substrate. As the enzyme and substrate come together, their interaction causes a mild...
Ligand Binding and Linkage00:49

Ligand Binding and Linkage

Allosteric proteins have more than one ligand binding site; the binding of a ligand to any of these sites influences the binding of ligands to the other sites. When a protein is allosteric, its binding sites are called coupled or linked.  In the case of enzymes, the site that binds to the substrate is known as the active site and the other site is known as the regulatory site. When a ligand binds to the regulatory site, this leads to conformational changes in the protein that can influence the...
Gene Families01:57

Gene Families

Gene families consist of groups of genes proposed to have originated from a common ancestor. Typically these arise through events in which a gene or genes are mistakenly duplicated during cell division. Unlike their parent genes (which are subject to selection pressure to maintain function), these gene copies do not need to preserve their sequences and may evolve at a relatively faster rate.
Occasionally these regions can be adapted to take on new roles within the organism, becoming novel genes...